Scheme & Guidelines
Title Download
Extension Notice
Revised notice for re-invitation of application -
Inclusion of new product - Ofloxacin
Inclusion of new product - Erythromycin Thiocynate (TIOC)
Inclusion of new product - CDA and increase in capacity of eligible product - Artesunate
Notice for Inviting 2nd Round of Applications
Scheme Notification
Guidelines
Presentation
FAQ
Banck A/C Details for Fee Payment
ACCOUNT NAME IFCI PLI BULK DRUGS
ACCOUNT NO. 3859475896
Name of the Bank Central Bank of India
BRANCH CODE 1410
BRANCH IFSC CODE CBIN0281410
BRANCH NAME Nehru Place
ADDRESS 59, Shakuntala Building, Nehru Place , New Delhi-110019
Contact Email
  • bdpli[at]ifciltd[dot]com
  • pharma-bureau[at]gov[dot]in